Last reviewed · How we verify
CM-CS1 T-cell infusion
CM-CS1 T-cell infusion is a Biologic drug developed by Celyad Oncology SA. It is currently in Phase 1 development.
At a glance
| Generic name | CM-CS1 T-cell infusion |
|---|---|
| Sponsor | Celyad Oncology SA |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Study of Pembrolizumab Treatment After CYAD-101 With FOLFOX Preconditioning in Metastatic Colorectal Cancer (PHASE1)
- alloSHRINK - Standard cHemotherapy Regimen and Immunotherapy With Allogeneic NKG2D-based CYAD-101 Chimeric Antigen Receptor T-cells (PHASE1)
- Dose Escalation and Dose Expansion Phase I Study to Assess the Safety and Clinical Activity of Multiple Doses of NKR-2 Administered Concurrently With FOLFOX in Colorectal Cancer With Potentially Resectable Liver Metastases (PHASE1)
- Safety Study of Chimeric Antigen Receptor Modified T-cells Targeting NKG2D-Ligands (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- CM-CS1 T-cell infusion CI brief — competitive landscape report
- CM-CS1 T-cell infusion updates RSS · CI watch RSS
- Celyad Oncology SA portfolio CI
Frequently asked questions about CM-CS1 T-cell infusion
What is CM-CS1 T-cell infusion?
CM-CS1 T-cell infusion is a Biologic drug developed by Celyad Oncology SA.
Who makes CM-CS1 T-cell infusion?
CM-CS1 T-cell infusion is developed by Celyad Oncology SA (see full Celyad Oncology SA pipeline at /company/celyad-oncology-sa).
What development phase is CM-CS1 T-cell infusion in?
CM-CS1 T-cell infusion is in Phase 1.
Related
- Manufacturer: Celyad Oncology SA — full pipeline
- Compare: CM-CS1 T-cell infusion vs similar drugs
- Pricing: CM-CS1 T-cell infusion cost, discount & access